See more : Wayne Savings Bancshares, Inc. (WAYN) Income Statement Analysis – Financial Results
Complete financial analysis of Welby Inc. (4438.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Welby Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Damaris SA (MLDAM.PA) Income Statement Analysis – Financial Results
- Redwood Trust, Inc. (RWT-PA) Income Statement Analysis – Financial Results
- Stora Enso Oyj (0CX9.L) Income Statement Analysis – Financial Results
- Sernova Corp. (SEOVF) Income Statement Analysis – Financial Results
- Loomis AB (publ) (LOIMF) Income Statement Analysis – Financial Results
Welby Inc. (4438.T)
About Welby Inc.
Welby Inc. provides digital health solutions that help patients to get medical care services. The company offers services in the areas of diabetes mellitus, lifestyle related disease, mental illness, autoimmune disease, neurological disease, rare disease, oncology, and pain. It also engages in the medical data survey business; and operates Welby My Carte platform. The company was incorporated in 2011 and is based in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 575.00M | 1.05B | 1.14B | 864.64M | 798.52M | 808.01M | 474.75M | 253.46M |
| Cost of Revenue | 199.00M | 295.55M | 455.27M | 358.35M | 179.61M | 255.97M | 221.96M | 73.42M |
| Gross Profit | 376.00M | 755.44M | 683.92M | 506.30M | 618.90M | 552.04M | 252.80M | 180.05M |
| Gross Profit Ratio | 65.39% | 71.88% | 60.04% | 58.56% | 77.51% | 68.32% | 53.25% | 71.03% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.24M |
| General & Administrative | 47.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 766.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 813.00M | 692.68M | 796.72M | 732.16M | 602.34M | 395.96M | 326.16M | 287.01M |
| Other Expenses | 0.00 | 694.53M | 797.04M | 743.84M | 602.34M | -1.81M | -2.14M | 177.00K |
| Operating Expenses | 813.00M | 694.53M | 797.04M | 743.84M | 602.34M | 395.96M | 326.16M | 316.24M |
| Cost & Expenses | 1.01B | 990.09M | 1.25B | 1.10B | 781.95M | 651.92M | 548.11M | 389.66M |
| Interest Income | 8.00K | 10.00K | 11.00K | 14.00K | 15.00K | 7.00K | 1.00K | 9.00K |
| Interest Expense | 20.00K | 53.00K | 86.00K | 116.00K | 142.00K | 321.00K | 593.00K | 112.00K |
| Depreciation & Amortization | 2.00M | 2.08M | 604.00K | 22.42M | 7.97M | 5.11M | 4.11M | 5.51M |
| EBITDA | -435.00M | 40.29M | -127.70M | -309.28M | 3.47M | 159.39M | -71.39M | -130.50M |
| EBITDA Ratio | -75.65% | 7.21% | -9.57% | -24.92% | 0.64% | 19.73% | -15.04% | -51.49% |
| Operating Income | -437.00M | 60.91M | -113.12M | -237.54M | -2.86M | 156.08M | -73.36M | -136.20M |
| Operating Income Ratio | -76.00% | 5.80% | -9.93% | -27.47% | -0.36% | 19.32% | -15.45% | -53.73% |
| Total Other Income/Expenses | -66.00M | -22.76M | -15.26M | -94.28M | -21.22M | -2.12M | -2.73M | 74.00K |
| Income Before Tax | -503.00M | 38.15M | -128.39M | -331.82M | -4.65M | 153.96M | -76.09M | -136.12M |
| Income Before Tax Ratio | -87.48% | 3.63% | -11.27% | -38.38% | -0.58% | 19.05% | -16.03% | -53.70% |
| Income Tax Expense | 2.00M | 4.24M | 2.29M | 21.27M | 6.65M | -22.61M | 870.00K | 290.00K |
| Net Income | -505.00M | 33.91M | -130.68M | -353.09M | -11.30M | 176.57M | -76.96M | -136.41M |
| Net Income Ratio | -87.83% | 3.23% | -11.47% | -40.84% | -1.42% | 21.85% | -16.21% | -53.82% |
| EPS | -64.47 | 4.33 | -16.68 | -45.18 | -1.47 | 31.19 | -13.15 | -17.67 |
| EPS Diluted | -64.47 | 4.33 | -16.68 | -45.18 | -1.47 | 31.19 | -13.15 | -17.67 |
| Weighted Avg Shares Out | 7.83M | 7.83M | 7.83M | 7.81M | 7.69M | 5.66M | 5.85M | 7.72M |
| Weighted Avg Shares Out (Dil) | 7.83M | 7.84M | 7.83M | 7.81M | 7.69M | 5.66M | 5.85M | 7.72M |
Source: https://incomestatements.info
Category: Stock Reports